1 Department of Radiology, University of California, Davis Medical Center, 4860 Y St, Ste 3100, Sacramento, CA 95817.
2 Department of Radiology, George Washington University Hospital, Washington, DC.
AJR Am J Roentgenol. 2018 Dec;211(6):1259-1263. doi: 10.2214/AJR.18.19744. Epub 2018 Sep 21.
The objective of our study was to determine the attenuation range of homogeneous papillary renal cell carcinomas (RCCs) on contrast-enhanced CT.
This retrospective study was performed at two institutions from January 1, 2007, to January 1, 2017. Multiphasic CT studies with and without IV contrast material of 114 patients with pathologically proven papillary RCCs were independently reviewed by two sets of two abdominal radiologists. Seventy-two cases were excluded because of subjective lesion heterogeneity, leaving 42 homogeneous RCCs. Three ROIs were placed on all lesions for all CT phases, and the mean attenuations were calculated.
Mean lesion size was 2.8 cm (range, 1.2-11.0 cm). The attenuation range for each CT phase was as follows: unenhanced, 14.7-50.7 HU; corticomedullary, 32.2-99.5 HU; portal venous, 40.8-95.1 HU; nephrographic, 17.9-90.8 HU; and excretory, 18.0-73.0 HU. Two of 114 (1.8%; 95% CI, 0.2-6.5%) RCCs were homogeneous and less than 30 HU on the portal venous or nephrographic phase. One of these RCCs was a solid hypoenhancing mass, and the other was a homogeneous cystic RCC. Of the cases with an unenhanced phase, three of 107 (2.8%; 95% CI, 0.6-8.8%) were both homogeneous and were less than 20 HU in attenuation.
Papillary RCCs are rarely both subjectively homogeneous and less than 20 HU at unenhanced CT and less than 30 HU at portal venous or nephrographic phase CT.
本研究旨在确定均质型肾细胞癌(RCC)在增强 CT 上的衰减范围。
本回顾性研究于 2007 年 1 月 1 日至 2017 年 1 月 1 日在两家机构进行。两位腹部放射科医生分别独立地对 114 例经病理证实为乳头状 RCC 的患者进行了多期 CT 检查,包括有无静脉注射对比剂。72 例因主观病变异质性而被排除,留下 42 例均质 RCC。在所有 CT 期,在所有病变上放置 3 个 ROI,并计算平均衰减值。
平均病变大小为 2.8cm(范围 1.2-11.0cm)。各 CT 期的衰减范围如下:平扫 14.7-50.7HU;皮质期 32.2-99.5HU;门静脉期 40.8-95.1HU;肾实质期 17.9-90.8HU;排泄期 18.0-73.0HU。114 例中 2 例(1.8%;95%CI 0.2-6.5%)RCC 在门静脉或肾实质期为均质且小于 30HU。其中 1 例为实性低增强肿块,另 1 例为均质囊性 RCC。在平扫期的 107 例中,有 3 例(2.8%;95%CI 0.6-8.8%)为均质且衰减值小于 20HU。
在平扫 CT 上,小于 20HU,在门静脉或肾实质期 CT 上小于 30HU,均质型 RCC 极为罕见。